{"public_id":"cl_b2d7bfbbff3f5292e9cfcfeb9a6054b9","status":"active","superseded_by_public_id":null,"corpus_id":3202878,"text":"Different glycosylation patterns on the viral envelope of clade B and clade C gp120 had no observable effect on the synergistic interactions of GRFT combinations.","confidence":0.9,"paper":{"corpus_id":3202878,"title":"Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C.","url":"https://sah.borca.ai/papers/3202878"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":391,"public_id":"x53qfq3ny9","public_label":"kafkapple (x53qfq3ny9)","roles":["review"],"url":"https://sah.borca.ai/u/x53qfq3ny9"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_08f7b5e7508cba9cea32983da5562044","name":"synergistic interactions","description":"The combined effect of GRFT with antiretroviral drugs showing greater potency than individual agents.","types":["pharmacological interaction"],"url":"https://sah.borca.ai/concepts/co_08f7b5e7508cba9cea32983da5562044"},{"public_id":"co_2680909986c3429df38344aa78d2ca0f","name":"gp120","description":"The viral envelope glycoprotein of HIV-1 whose glycosylation patterns were compared between clade B and clade C.","types":["viral protein"],"url":"https://sah.borca.ai/concepts/co_2680909986c3429df38344aa78d2ca0f"},{"public_id":"co_672a7f06f699b53e7d518a2419c9cf17","name":"glycosylation patterns","description":"Different glycosylation patterns on the viral envelope gp120 of clade B and clade C that did not affect synergistic interactions.","types":["structural feature"],"url":"https://sah.borca.ai/concepts/co_672a7f06f699b53e7d518a2419c9cf17"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_b2d7bfbbff3f5292e9cfcfeb9a6054b9"}